Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Stem Cell Research

  Free Subscription


Articles published in Bone Marrow Transplant

Retrieve available abstracts of 219 articles:
HTML format
Text format



Single Articles


    October 2018
  1. KUROSAWA S, Yamaguchi T, Oshima K, Yanagisawa A, et al
    Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey.
    Bone Marrow Transplant. 2018 Oct 4. pii: 10.1038/s41409-018-0343.
    PubMed     Text format    


  2. BAE SK, Gushima T, Saito N, Yamanaka I, et al
    HBV reactivation after hematopoietic stem cell transplantation and rituximab-containing chemotherapy: a 12-year experience at a single center.
    Bone Marrow Transplant. 2018 Oct 4. pii: 10.1038/s41409-018-0355.
    PubMed     Text format    


  3. MOUKALLED NM, El Darsa H, Haibe Y, Massoud R, et al
    Feasibility of Venetoclax-based combinations for adult patients with acute myeloid leukemia relapsing after allogenic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 4. pii: 10.1038/s41409-018-0347.
    PubMed     Text format    


  4. PAHNKE S, Egeland T, Halter J, Hagglund H, et al
    Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation.
    Bone Marrow Transplant. 2018 Oct 3. pii: 10.1038/s41409-018-0350.
    PubMed     Text format     Abstract available


  5. DOS SANTOS KB, Costa LJM, Bettarello G, da Matta Abreu M, et al
    LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma.
    Bone Marrow Transplant. 2018 Oct 3. pii: 10.1038/s41409-018-0349.
    PubMed     Text format    


  6. PINGEL J, Wang T, Hagenlocher Y, Hernandez-Frederick CJ, et al
    The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation - a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR.
    Bone Marrow Transplant. 2018 Oct 2. pii: 10.1038/s41409-018-0345.
    PubMed     Text format     Abstract available


    September 2018
  7. SMELAND KB, Loge JH, Aass HCD, Aspelin T, et al
    Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity.
    Bone Marrow Transplant. 2018 Sep 27. pii: 10.1038/s41409-018-0342.
    PubMed     Text format    


  8. JAIME-PEREZ JC, Salazar-Cavazos L, Aguilar-Calderon P, Herrera-Garza JL, et al
    Assessing the efficacy of an ambulatory peripheral blood hematopoietic stem cell transplant program using reduced intensity conditioning in a low-middle-income country.
    Bone Marrow Transplant. 2018 Sep 21. pii: 10.1038/s41409-018-0338.
    PubMed     Text format     Abstract available


  9. SALEEM MS, Aljurf M, Srivastava A, Shamsi T, et al
    Challenges in managing graft-versus-host disease in developing countries: a perspective.
    Bone Marrow Transplant. 2018 Sep 20. pii: 10.1038/s41409-018-0333.
    PubMed     Text format     Abstract available


  10. BONIFAZI F, Dan E, Labopin M, Sessa M, et al
    Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study.
    Bone Marrow Transplant. 2018 Sep 19. pii: 10.1038/s41409-018-0335.
    PubMed     Text format     Abstract available


  11. NAFTULIN JS, Penzi LR, Manatis-Lornell A, Yasuda MR, et al
    Longstanding alopecia and nail dystrophy are associated with more severe overall chronic graft-versus-host disease in adults.
    Bone Marrow Transplant. 2018 Sep 13. pii: 10.1038/s41409-018-0309.
    PubMed     Text format    


    August 2018
  12. KAMEDA K, Kimura SI, Misaki Y, Yoshimura K, et al
    Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 31. pii: 10.1038/s41409-018-0330.
    PubMed     Text format     Abstract available


  13. TSANG ES, Villa D, Loscocco F, Visani G, et al
    High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 31. pii: 10.1038/s41409-018-0328.
    PubMed     Text format    


  14. LIN RJ, Elko TA, Perales MA, Alexander K, et al
    End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer center.
    Bone Marrow Transplant. 2018 Aug 22. pii: 10.1038/s41409-018-0311.
    PubMed     Text format     Abstract available


  15. MOHANAN E, Panetta JC, Lakshmi KM, Edison ES, et al
    Correction: Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 22. pii: 10.1038/s41409-018-0276.
    PubMed     Text format     Abstract available


  16. CHAULAGAIN CP, Sprague KA, Pilichowska M, Cowan J, et al
    Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
    Bone Marrow Transplant. 2018 Aug 20. pii: 10.1038/s41409-018-0299.
    PubMed     Text format     Abstract available


  17. YAKUSHIJIN K, Ikezoe T, Ohwada C, Kudo K, et al
    Clinical effects of recombinant thrombomodulin and defibrotide on sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 20. pii: 10.1038/s41409-018-0304.
    PubMed     Text format     Abstract available


  18. KANELLOPOULOS A, Kaparou M, Xenou E, Paneesha S, et al
    Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemia.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0297.
    PubMed     Text format     Abstract available


  19. LADETTO M, Bottcher S, Kroger N, Pulsipher MA, et al
    Methods and role of minimal residual disease after stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0307.
    PubMed     Text format     Abstract available


  20. PICCALUGA PP, Rapezzi D, Gazzola A, Malagola M, et al
    Resolving the diagnostic dilemma of T-cell clonal expansion after hematopoietic stem cell transplantation in T-cell lymphoma patients by TCR-gamma next generation sequencing.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0268.
    PubMed     Text format    


  21. MILLER KC, Gertz MA, Buadi FK, Hayman SR, et al
    Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myeloma.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0302.
    PubMed     Text format     Abstract available


  22. GUNES G, Goker H, Demiroglu H, Malkan UY, et al
    Extramedullary relapses of acute leukemias after allogeneic hematopoietic stem cell transplantation: clinical features, cumulative incidence, and risk factors.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0303.
    PubMed     Text format     Abstract available


  23. MATSUDA K, Honda A, Arai S, Maki H, et al
    Retrospective analysis on transient recurrence of steroid-sensitive acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0274.
    PubMed     Text format    


  24. DABAS R, Dharmani-Khan P, Modi M, Van Slyke T, et al
    Anti-thymocyte globulin's activity against acute myeloid leukemia stem cells.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0296.
    PubMed     Text format     Abstract available


  25. BITTENCOURT MCB, Mariano L, Moreira F, Schmidt-Filho J, et al
    Cryopreserved versus non-cryopreserved peripheral blood stem cells for autologous transplantation after high-dose Melphalan in multiple myeloma: comparative analysis.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0250.
    PubMed     Text format    


  26. KRAFT S, Bollinger N, Bodenmann B, Heim D, et al
    High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0293.
    PubMed     Text format     Abstract available


  27. PHILIPPE M, Neely M, Rushing T, Bertrand Y, et al
    Maximal concentration of intravenous busulfan as a determinant of veno-occlusive disease: a pharmacokinetic-pharmacodynamic analysis in 293 hematopoietic stem cell transplanted children.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0281.
    PubMed     Text format     Abstract available


  28. MARTELIN E, Volin L, Itala-Remes M, Niittyvuopio R, et al
    Incidence and risk factors of secondary cancers after allogeneic stem cell transplantation: analysis of a single centre cohort with a long follow-up.
    Bone Marrow Transplant. 2018 Aug 13. pii: 10.1038/s41409-018-0290.
    PubMed     Text format    


  29. DOUCETTE K, Tian X, Chawla U, Jain NA, et al
    Premature coronary artery disease following allogeneic stem cell transplantation: an NHLBI Cohort Study.
    Bone Marrow Transplant. 2018 Aug 13. pii: 10.1038/s41409-018-0282.
    PubMed     Text format    


  30. PHILLIPS EH, Lannon MM, Lopes A, Chadwick H, et al
    High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study.
    Bone Marrow Transplant. 2018 Aug 13. pii: 10.1038/s41409-018-0294.
    PubMed     Text format    


  31. VARGA C, Comenzo RL
    High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review.
    Bone Marrow Transplant. 2018 Aug 8. pii: 10.1038/s41409-018-0284.
    PubMed     Text format     Abstract available


  32. KEREP AZ, Broome J, Pirsl F, Curtis LM, et al
    Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients.
    Bone Marrow Transplant. 2018 Aug 8. pii: 10.1038/s41409-018-0224.
    PubMed     Text format     Abstract available


  33. PERIC Z, Skegro I, Durakovic N, Desnica L, et al
    Amniotic membrane transplantation-a new approach to crossing the HLA barriers in the treatment of refractory ocular graft-versus-host disease.
    Bone Marrow Transplant. 2018 Aug 8. pii: 10.1038/s41409-018-0140.
    PubMed     Text format    


  34. MUKHERJEE A, Ekinci E, Scholoff A, Obi G, et al
    Voriconazole photosensitivity causes apparent graft-versus-host disease exacerbation.
    Bone Marrow Transplant. 2018 Aug 7. pii: 10.1038/s41409-018-0285.
    PubMed     Text format    


  35. KONISHI Y, Kondo T, Nakao K, Asagoe K, et al
    Allogeneic hematopoietic stem cell transplantation for 8p11 myeloproliferative syndrome with BCR-FGFR1 gene rearrangement: a case report and literature review.
    Bone Marrow Transplant. 2018 Aug 7. pii: 10.1038/s41409-018-0287.
    PubMed     Text format    


  36. SUGITA J, Kagaya Y, Miyamoto T, Shibasaki Y, et al
    Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2018 Aug 7. pii: 10.1038/s41409-018-0279.
    PubMed     Text format     Abstract available


  37. BALDOMERO H, Aljurf M, Zaidi SZA, Hashmi SK, et al
    Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends.
    Bone Marrow Transplant. 2018 Aug 6. pii: 10.1038/s41409-018-0275.
    PubMed     Text format     Abstract available


  38. VAN DER HEIDEN PLJ, Arbous MS, van Beers EJ, van den Bergh WM, et al
    Predictors of short-term and long-term mortality in critically ill patients admitted to the intensive care unit following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 6. pii: 10.1038/s41409-018-0277.
    PubMed     Text format     Abstract available


    July 2018
  39. HIRANO M, Jimbo K, Ogawa M, Ochi K, et al
    Chronic inflammatory demyelinating polyneuropathy in adult T-cell leukemia-lymphoma patients following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0202.
    PubMed     Text format    


  40. SAITO A, Nishikawa T, Oyoshi T, Nakagawa S, et al
    Giant radiation-induced cavernous haemangioma before reduced-intensity bone marrow transplantation for acute lymphoblastic leukaemia.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0272.
    PubMed     Text format    


  41. CHEN YB, McCarthy PL, Hahn T, Holstein SA, et al
    Methods to prevent and treat relapse after hematopoietic stem cell transplantation with tyrosine kinase inhibitors, immunomodulating drugs, deacetylase inhibitors, and hypomethylating agents.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0269.
    PubMed     Text format     Abstract available


  42. BHUTANI D, Jaiyeoba C, Kim S, Naylor P, et al
    Relationship between clostridium difficile infection and gastrointestinal graft versus host disease in recipients of allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0270.
    PubMed     Text format    


  43. HAGEN PA, Adams W, Smith S, Tsai S, et al
    Low mean post-transplantation tacrolimus levels in weeks 2-3 correlate with acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation from related and unrelated donors.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0267.
    PubMed     Text format    


  44. TAY J, Daly A, Jamani K, Labelle L, et al
    Patient eligibility for hematopoietic stem cell transplantation: a review of patient-associated variables.
    Bone Marrow Transplant. 2018 Jul 9. pii: 10.1038/s41409-018-0265.
    PubMed     Text format     Abstract available


  45. GONSALVES WI, Buadi FK, Ailawadhi S, Bergsagel PL, et al
    Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.
    Bone Marrow Transplant. 2018 Jul 9. pii: 10.1038/s41409-018-0264.
    PubMed     Text format     Abstract available


  46. YANG B, Yu R, Cai L, Bin Guo, et al
    Haploidentical versus matched donor stem cell transplantation for patients with hematological malignancies: a systemic review and meta-analysis.
    Bone Marrow Transplant. 2018 Jul 9. pii: 10.1038/s41409-018-0239.
    PubMed     Text format     Abstract available


    June 2018
  47. TOMIZAWA D, Yoshida M, Kondo T, Miyamura T, et al
    Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases.
    Bone Marrow Transplant. 2018 Jun 29. pii: 10.1038/s41409-018-0273.
    PubMed     Text format     Abstract available


  48. TANG S, Shen H, Qu C, Dai H, et al
    Ikaros family zinc-finger 1 mutation is an independent factor for the poor prognosis of adult B-cell acute lymphoblastic leukemia, and allogeneic hematopoietic stem cell transplantation can improve clinical outcomes.
    Bone Marrow Transplant. 2018 Jun 25. pii: 10.1038/s41409-018-0249.
    PubMed     Text format     Abstract available


  49. CHUNG H, Hong KT, Lee JW, Rhee SJ, et al
    Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patients.
    Bone Marrow Transplant. 2018 Jun 18. pii: 10.1038/s41409-018-0260.
    PubMed     Text format     Abstract available


  50. HARI P, Reece DE, Randhawa J, Flomenberg N, et al
    Final outcomes of escalated melphalan 280 mg/m(2) with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival.
    Bone Marrow Transplant. 2018 Jun 15. pii: 10.1038/s41409-018-0261.
    PubMed     Text format     Abstract available


  51. NYGAARD M, Karlsmark T, Andersen NS, Schjodt IM, et al
    Extracorporeal photopheresis is a valuable treatment option in steroid-refractory or steroid-dependent acute graft versus host disease-experience with three different approaches.
    Bone Marrow Transplant. 2018 Jun 15. pii: 10.1038/s41409-018-0262.
    PubMed     Text format    


  52. MALARD F, Gasc C, Plantamura E, Dore J, et al
    High gastrointestinal microbial diversity and clinical outcome in graft-versus-host disease patients.
    Bone Marrow Transplant. 2018 Jun 14. pii: 10.1038/s41409-018-0254.
    PubMed     Text format    


  53. WONG E, Davis JE, Grigg A, Szer J, et al
    Strategies to enhance the graft versus tumour effect after allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jun 14. pii: 10.1038/s41409-018-0244.
    PubMed     Text format     Abstract available


  54. SOLANO C, Gimenez E, Albert E, Mateo EM, et al
    Pre-engraftment cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: incidence, risk factors, and clinical outcomes.
    Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0251.
    PubMed     Text format     Abstract available


  55. GABELLI M, Zecca M, Messina C, Carraro E, et al
    Hematopoietic stem cell transplantation for isolated extramedullary relapse of acute lymphoblastic leukemia in children.
    Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0259.
    PubMed     Text format     Abstract available


  56. HOCHBERG J, Zahler S, Geyer MB, Chen N, et al
    The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leuke
    Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0247.
    PubMed     Text format     Abstract available


  57. NADEMI Z, Wynn RF, Slatter M, Hughes SM, et al
    Hematopoietic stem cell transplantation for cytidine triphosphate synthase 1 (CTPS1) deficiency.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0246.
    PubMed     Text format    


  58. MOOR I, Bacher VU, Jeker B, Taleghani BM, et al
    Peripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myeloma.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0245.
    PubMed     Text format    


  59. DOESCHER A, Casper J, Kraemer D, Kapels HH, et al
    Digital PCR to assess platelet recovery after stem cell transplantation.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0238.
    PubMed     Text format    


  60. WHITE PS, Phull P, Brauneis D, Sloan JM, et al
    High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0242.
    PubMed     Text format    


  61. AL-SAUD B, Al-Jomaie M, Al-Ghonaium A, Al-Ahmari A, et al
    Haematopoietic stem cell transplant for hyper-IgM syndrome due to CD40 defects: a single-centre experience.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0219.
    PubMed     Text format     Abstract available


  62. GRIFFIN SP, Wheeler SE, Wiggins LE, Murthy HS, et al
    Pharmacokinetic and clinical outcomes when ideal body weight is used to dose busulfan in obese hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0240.
    PubMed     Text format     Abstract available


  63. ROBINSON SP, Boumendil A, Finel H, Dreger P, et al
    High-dose therapy with BEAC conditioning compared to BEAM conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: no differences in toxicity or outcome. A matched-control study of the EBMT-Lymphoma Working Party.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0196.
    PubMed     Text format     Abstract available


  64. SORENSEN CD, Moller BK, Olesen G, Hokland P, et al
    Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0229.
    PubMed     Text format    


  65. SCHOEMANS HM, Lee SJ, Ferrara JL, Wolff D, et al
    EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.
    Bone Marrow Transplant. 2018 Jun 5. pii: 10.1038/s41409-018-0204.
    PubMed     Text format    


    May 2018
  66. BURT RK, Han X, Gozdziak P, Yaung K, et al
    Five year follow-up after autologous peripheral blood hematopoietic stem cell transplantation for refractory, chronic, corticosteroid-dependent systemic lupus erythematosus: effect of conditioning regimen on outcome.
    Bone Marrow Transplant. 2018 May 31. pii: 10.1038/s41409-018-0173.
    PubMed     Text format     Abstract available


  67. MA CKK, Garcia-Cadenas I, Fox ML, Ai S, et al
    Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0215.
    PubMed     Text format    


  68. SUREDA A, Dreger P, Bishop MR, Kroger N, et al
    Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0214.
    PubMed     Text format     Abstract available


  69. JAIN T, Kunze KL, Temkit M, Partain DK, et al
    Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0226.
    PubMed     Text format     Abstract available


  70. GANETSKY A, Frey NV, Hexner EO, Loren AW, et al
    Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0236.
    PubMed     Text format     Abstract available


  71. KATO M, Kurata M, Kanda J, Kato K, et al
    Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0221.
    PubMed     Text format     Abstract available


  72. GOKBUGET N, Canaani J, Nagler A, Bishop M, et al
    Prevention and treatment of relapse after stem cell transplantation with immunotherapy.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0232.
    PubMed     Text format     Abstract available


  73. FALKENBURG F, Ruggiero E, Bonini C, Porter D, et al
    Prevention and treatment of relapse after stem cell transplantation by cellular therapies.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0227.
    PubMed     Text format     Abstract available


  74. PHAN TL, Pritchett JC, Leifer C, Zerr DM, et al
    HHV-6B infection, T-cell reconstitution, and graft-vs-host disease after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0225.
    PubMed     Text format     Abstract available


  75. FUJI S, Kurosawa S, Inamoto Y, Murata T, et al
    Decision analysis of up-front autologous hematopoietic stem cell transplantation in patients with peripheral T-cell lymphoma.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0223.
    PubMed     Text format    


  76. MANJAPPA S, Fiala MA, King J, Kohnen DA, et al
    The efficacy of salvage autologous stem cell transplant among patients with multiple myeloma who received maintenance therapy post initial transplant.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0216.
    PubMed     Text format    


  77. JACOBSE J, Mensink H, van der Stoep-Yap MYEC, Kollen WJW, et al
    Long-term aprepitant for nausea and vomiting associated with gastroparesis in hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0231.
    PubMed     Text format    


  78. DAMLAJ M, Alaskar A, Ghazi S, Alahmari B, et al
    Peripheral hematopoietic stem cell mobilization utilizing growth factors in donors with sickle cell trait is safe and effective.
    Bone Marrow Transplant. 2018 May 9. pii: 10.1038/s41409-018-0208.
    PubMed     Text format    


  79. TKACZYK ER, Chen F, Wang J, Gandelman JS, et al
    Overcoming human disagreement assessing erythematous lesion severity on 3D photos of chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 May 8. pii: 10.1038/s41409-018-0211.
    PubMed     Text format    


  80. SATO T, Seto A, Kagaya Y, Kawashima N, et al
    Iodine staining and p16 immunohistochemistry as a novel screening for secondary esophageal neoplasm after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 May 8. pii: 10.1038/s41409-018-0197.
    PubMed     Text format    


  81. NYGAARD M, Karlsmark T, Andersen NS, Schjodt IM, et al
    Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host disease.
    Bone Marrow Transplant. 2018 May 8. pii: 10.1038/s41409-018-0206.
    PubMed     Text format     Abstract available


  82. TAGEJA N, Korde N, Kazandjian D, Panch S, et al
    Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0170.
    PubMed     Text format     Abstract available


  83. KONUMA T, Kohara C, Watanabe E, Mizukami M, et al
    Circulating monocyte subsets in human chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0187.
    PubMed     Text format     Abstract available


  84. SAAD A, Taneja A, Di Stasi A, Sarmad R, et al
    Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0185.
    PubMed     Text format    


  85. ASLAM HM, Yousuf S, Kassim A, Iqbal SM, et al
    Hematopoietic stem cell transplantation for adult sickle cell disease in the era of universal donor availibility.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0193.
    PubMed     Text format     Abstract available


  86. CHEN Y, Xu LP, Zhang XH, Chen H, et al
    Busulfan, Fludarabine, and Cyclophosphamide (BFC) conditioning allowed stable engraftment after haplo-identical allogeneic stem cell transplantation in children with adrenoleukodystrophy and mucopolysaccharidosis.
    Bone Marrow Transplant. 2018 May 3. pii: 10.1038/s41409-018-0175.
    PubMed     Text format    


  87. SELLMANN L, Rabe K, Bunting I, Dammann E, et al
    Diagnostic value of highly-sensitive chimerism analysis after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 May 2. pii: 10.1038/s41409-018-0176.
    PubMed     Text format     Abstract available


    April 2018
  88. YANG L, Tan Y, Shi J, Zhao Y, et al
    Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma.
    Bone Marrow Transplant. 2018 Apr 30. pii: 10.1038/s41409-018-0184.
    PubMed     Text format    


  89. GUTIERREZ-GARCIA G, Rovira M, Magnano L, Rosinol L, et al
    Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 29. pii: 10.1038/s41409-018-0189.
    PubMed     Text format     Abstract available


  90. PRESTES DP, Mendes C, Batista MV, Ramos JF, et al
    A case-series of Toxoplasmosis in hematopoietic stem cell transplantation: still a concern for endemic countries.
    Bone Marrow Transplant. 2018 Apr 27. pii: 10.1038/s41409-018-0179.
    PubMed     Text format    


  91. AERTS-KAYA F, Koca G, Sharafi P, Sayla FC, et al
    Automated washing of long-term cryopreserved peripheral blood stem cells promotes cell viability and preserves CD34+ cell numbers.
    Bone Marrow Transplant. 2018 Apr 27. pii: 10.1038/s41409-018-0192.
    PubMed     Text format    


  92. NOGUCHI M, Moritake H, Kamimura S, Sonoda M, et al
    Adalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet's disease and secondary myelodysplastic syndrome.
    Bone Marrow Transplant. 2018 Apr 27. pii: 10.1038/s41409-018-0180.
    PubMed     Text format    


  93. SOLANO C, Talaya A, Gimenez E, Albert E, et al
    Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: when should genotypic drug resistance testing be requested?
    Bone Marrow Transplant. 2018 Apr 26. pii: 10.1038/s41409-018-0191.
    PubMed     Text format    


  94. BROWNBACK KR, Pitts LR, Abhyankar S
    Safety of nintedanib for treatment of fibrotic lung disease after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 26. pii: 10.1038/s41409-018-0182.
    PubMed     Text format    


  95. JODELE S, Dandoy CE, Myers K, Wallace G, et al
    High-dose Carboplatin/Etoposide/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma.
    Bone Marrow Transplant. 2018 Apr 19. pii: 10.1038/s41409-018-0159.
    PubMed     Text format     Abstract available


  96. HOROWITZ M, Schreiber H, Elder A, Heidenreich O, et al
    Epidemiology and biology of relapse after stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 18. pii: 10.1038/s41409-018-0171.
    PubMed     Text format    


  97. PEREZ L, Fernandez H, Horna P, Riches M, et al
    Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Apr 18. pii: 10.1038/s41409-018-0163.
    PubMed     Text format     Abstract available


  98. GRECO R, Ciceri F, Noviello M, Bondanza A, et al
    Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP.
    Bone Marrow Transplant. 2018 Apr 17. pii: 10.1038/s41409-018-0167.
    PubMed     Text format    


  99. PERIC Z, Wilson J, Durakovic N, Ostojic A, et al
    Early human cytomegalovirus reactivation is associated with lower incidence of relapse of myeloproliferative disorders after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 16. pii: 10.1038/s41409-018-0172.
    PubMed     Text format     Abstract available


  100. BATTIPAGLIA G, Ruggeri A, Labopin M, Volin L, et al
    Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemia.
    Bone Marrow Transplant. 2018 Apr 16. pii: 10.1038/s41409-018-0169.
    PubMed     Text format     Abstract available


    March 2018
  101. NAITHANI R, Dayal N, Pathak S, Rai R, et al
    Hematopoietic stem cell transplantation using non-cryopreserved peripheral blood stem cells graft is effective in multiple myeloma and lymphoma.
    Bone Marrow Transplant. 2018 Mar 29. pii: 10.1038/s41409-018-0174.
    PubMed     Text format    


  102. CASTAGNOLA E, Bagnasco F, Menoni S, Muraca M, et al
    Risk factors associated with development and mortality by invasive fungal diseases in pediatric allogeneic stem cell transplantation. A pediatric subgroup analysis of data from a prospective study of the Gruppo Italiano Trapianto di Midollo Osseo (GIT
    Bone Marrow Transplant. 2018 Mar 21. pii: 10.1038/s41409-018-0160.
    PubMed     Text format    


  103. YAHNG SA, Park SS, Jeon YW, Yoon JH, et al
    Successful outcomes of second hematopoietic stem cell transplantation with total nodal irradiation and ATG conditioning for graft failure in adult patients with severe aplastic anemia.
    Bone Marrow Transplant. 2018 Mar 21. pii: 10.1038/s41409-018-0154.
    PubMed     Text format     Abstract available


  104. GAAFAR A, Sheereen A, Almohareb F, Eldali A, et al
    Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community.
    Bone Marrow Transplant. 2018 Mar 16. pii: 10.1038/s41409-018-0123.
    PubMed     Text format     Abstract available


  105. VAN DER WAGEN L, Te Boome L, Schiffler M, Nijhof I, et al
    Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib.
    Bone Marrow Transplant. 2018 Mar 16. pii: 10.1038/s41409-018-0158.
    PubMed     Text format     Abstract available


  106. GASSAS A, Sivaprakasam P, Cummins M, Breslin P, et al
    High transplant-related mortality associated with haematopoietic stem cell transplantation for paediatric therapy-related acute myeloid leukaemia (t-AML). A study on behalf of the United Kingdom Paediatric Blood and Bone Marrow Transplant Group.
    Bone Marrow Transplant. 2018 Mar 15. pii: 10.1038/s41409-018-0157.
    PubMed     Text format     Abstract available


  107. BENEVENTI F, Locatelli E, Simonetta M, Cavagnoli C, et al
    Vaginal development and sexual functioning in young women after stem cell transplantation, chemotherapy, and/or radiotherapy for childhood hematological diseases.
    Bone Marrow Transplant. 2018 Mar 15. pii: 10.1038/s41409-018-0149.
    PubMed     Text format     Abstract available


  108. SCHMIDT V, Niederwieser D, Schenk T, Behre G, et al
    Efficacy and safety of keratinocyte growth factor (palifermin) for prevention of oral mucositis in TBI-based allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Mar 15. pii: 10.1038/s41409-018-0135.
    PubMed     Text format    


  109. KORDELAS L, da Silva Nardi F, Wagner B, Ditschkowski M, et al
    Elevated soluble human leukocyte antigen G levels in patients after allogeneic stem cell transplantation are associated with less severe acute and chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 Mar 14. pii: 10.1038/s41409-018-0145.
    PubMed     Text format     Abstract available


  110. RICHARDS S, Choo S, Mechinaud F, Cole T, et al
    Single centre results of targeted busulphan, fludarabine and serotherapy conditioning in haematopoietic stem cell transplantation for haemophagocytic lymphohistiocytosis.
    Bone Marrow Transplant. 2018 Mar 13. pii: 10.1038/s41409-018-0125.
    PubMed     Text format    


  111. CHUA CC, Lim HY, Chai KL, Ong J, et al
    Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma.
    Bone Marrow Transplant. 2018 Mar 9. pii: 10.1038/s41409-018-0152.
    PubMed     Text format     Abstract available


  112. TROEGER H, Hering NA, Bojarski C, Fromm A, et al
    Epithelial barrier dysfunction as permissive pathomechanism in human intestinal graft-versus-host disease.
    Bone Marrow Transplant. 2018 Mar 9. pii: 10.1038/s41409-018-0144.
    PubMed     Text format    


  113. DEBALS-GONTHIER M, Siani C, Faucher C, Touzani R, et al
    Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 years.
    Bone Marrow Transplant. 2018 Mar 9. pii: 10.1038/s41409-018-0133.
    PubMed     Text format     Abstract available


  114. LAMB LS, Pillai S, Langford S, Bowersock J, et al
    Clinical-scale manufacturing of gammadelta T cells for protection against infection and disease recurrence following haploidentical peripheral blood stem cell transplantation and cyclophosphamide gvhd prophylaxis.
    Bone Marrow Transplant. 2018 Mar 7. pii: 10.1038/s41409-018-0130.
    PubMed     Text format    


  115. PERIC Z, Botti S, Stringer J, Krawczyk J, et al
    Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT.
    Bone Marrow Transplant. 2018 Mar 7. pii: 10.1038/s41409-018-0137.
    PubMed     Text format     Abstract available


  116. CHENG Z, Zhou L, Hu K, Dai Y, et al
    Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Mar 7. pii: 10.1038/s41409-018-0146.
    PubMed     Text format     Abstract available


    February 2018
  117. GJAERDE LK, Schmidt M, Sengelov H
    Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Feb 28. pii: 10.1038/s41409-018-0131.
    PubMed     Text format    


  118. AVIVI I, Boumendil A, Finel H, Nagler A, et al
    Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2018 Feb 20. pii: 10.1038/s41409-017-0063.
    PubMed     Text format     Abstract available


  119. BUBALO J, Mulverhill K, Meyers G, Hayes-Lattin B, et al
    A randomized, placebo-controlled pilot trial of aprepitant combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients undergoing cyclophosphamide-based conditioning regimens prior to hematopoie
    Bone Marrow Transplant. 2018 Feb 20. pii: 10.1038/s41409-018-0106.
    PubMed     Text format     Abstract available


  120. SARMIENTO M, Ramirez P, Parody R, Salas MQ, et al
    Advantages of non-cryopreserved autologous hematopoietic stem cell transplantation against a cryopreserved strategy.
    Bone Marrow Transplant. 2018 Feb 13. pii: 10.1038/s41409-018-0117.
    PubMed     Text format     Abstract available


  121. MARCHESI F, Capria S, Giannarelli D, Trisolini SM, et al
    BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant.
    Bone Marrow Transplant. 2018 Feb 13. pii: 10.1038/s41409-018-0120.
    PubMed     Text format    


  122. WATTS MJ, Ings SJ, Dorman J, Rabin N, et al
    Use of split peripheral blood stem cell harvests in myeloma identifies functional preservation of progenitor cells cryopreserved for several years and demonstrates no functional damage to the bone marrow microenvironment.
    Bone Marrow Transplant. 2018 Feb 12. pii: 10.1038/s41409-018-0121.
    PubMed     Text format    


  123. HSU YT, Tsai HJ, Chang JS, Li SS, et al
    Stem cell transplantation for T-cell lymphomas in Taiwan.
    Bone Marrow Transplant. 2018 Feb 12. pii: 10.1038/s41409-018-0116.
    PubMed     Text format     Abstract available


  124. BORCHERT-MORLINS B, Memaran N, Sauer M, Maecker-Kolhoff B, et al
    Cardiovascular risk factors and subclinical organ damage after hematopoietic stem cell transplantation in pediatric age.
    Bone Marrow Transplant. 2018 Feb 9. pii: 10.1038/s41409-018-0104.
    PubMed     Text format     Abstract available


  125. MASHEGU H, Smith L, Li Y, Seif A, et al
    The role of peritoneal drainage in veno-occlusive disease in pediatric patients post hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2018 Feb 6. pii: 10.1038/s41409-018-0113.
    PubMed     Text format    


  126. TETU P, Jachiet M, de Masson A, Hurabielle C, et al
    Chronic graft versus host disease presenting as lichen planus pigmentosus.
    Bone Marrow Transplant. 2018 Feb 6. pii: 10.1038/s41409-018-0110.
    PubMed     Text format    


  127. OZDOGU H, Boga C, Yeral M, Kozanoglu I, et al
    Allogenic peripheral stem cell transplantation from HLA-matched related donors for adult sickle cell disease: remarkable outcomes from a single-center trial.
    Bone Marrow Transplant. 2018 Feb 5. pii: 10.1038/s41409-018-0111.
    PubMed     Text format     Abstract available


  128. YOO KH, Kang D, Kim IR, Choi EK, et al
    Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple study.
    Bone Marrow Transplant. 2018 Feb 5. pii: 10.1038/s41409-018-0097.
    PubMed     Text format     Abstract available


  129. ZHANG Q, Zhou Y, Majaw JK, Xu J, et al
    Acute appendicitis in leukaemia patients undergoing haematopoietic stem cell transplantation during the neutropaenic phase: a case series from a single BMT centre in China.
    Bone Marrow Transplant. 2018;53:219-222.
    PubMed     Text format    


  130. NYGAARD M, Andersen NS, Moser CE, Olesen G, et al
    Evaluation of infliximab as second-line treatment of acute graft versus host disease -validating response on day 7 and 28 as predictors of survival.
    Bone Marrow Transplant. 2018 Feb 1. pii: 10.1038/s41409-018-0099.
    PubMed     Text format     Abstract available


    January 2018
  131. PATHAK M, Diep PP, Lai X, Brinch L, et al
    Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation.
    Bone Marrow Transplant. 2018 Jan 30. pii: 10.1038/s41409-018-0090.
    PubMed     Text format     Abstract available


  132. TURCOTTE LM, Wang T, Hemmer MT, Spellman SR, et al
    Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation.
    Bone Marrow Transplant. 2018 Jan 30. pii: 10.1038/s41409-018-0100.
    PubMed     Text format    


  133. BADER P, Kuci Z, Bakhtiar S, Basu O, et al
    Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM).
    Bone Marrow Transplant. 2018 Jan 29. pii: 10.1038/s41409-018-0102.
    PubMed     Text format     Abstract available


  134. APITHY MJ, Charbonnier A, Desoutter J, Diouf M, et al
    Impact of MICA and NKG2D polymorphisms in HLA-fully matched related and unrelated hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 29. pii: 10.1038/s41409-017-0083.
    PubMed     Text format    


  135. CALBI V, Fumagalli F, Consiglieri G, Penati R, et al
    Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy.
    Bone Marrow Transplant. 2018 Jan 29. pii: 10.1038/s41409-017-0085.
    PubMed     Text format    


  136. FUJI S, Kurosawa S, Inamoto Y, Murata T, et al
    Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-017-0082.
    PubMed     Text format    


  137. COLTOFF A, Lancman G, Kim S, Steinberg A, et al
    Vedolizumab for treatment of steroid-refractory lower gastrointestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-018-0094.
    PubMed     Text format    


  138. ALHASHIM N, Aljurf M, Hassanein M, Chaudhri N, et al
    Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia: clinical characteristics, incidence, risk factors and outcomes.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-018-0093.
    PubMed     Text format     Abstract available


  139. MOHAMMED J, Akomolafe T, Aljurf M, Savani B, et al
    'To treat or not to treat': raising awareness on the effects of graft versus host disease drugs on musculoskeletal system.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-018-0095.
    PubMed     Text format    


  140. WOLFF D, Greinix H, Lee SJ, Gooley T, et al
    Biomarkers in chronic graft-versus-host disease: quo vadis?
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-018-0092.
    PubMed     Text format     Abstract available


  141. VAN DEN BRINK M, Uhrberg M, Jahn L, DiPersio JF, et al
    Selected biological issues affecting relapse after stem cell transplantation: role of T-cell impairment, NK cells and intrinsic tumor resistance.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-017-0078.
    PubMed     Text format     Abstract available


  142. KOTCHETKOV R, Dyszkiewicz-Korpanty A, Kukreti V
    Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-017-0080.
    PubMed     Text format    


  143. SAITO H, Ito M, Kato S, Kodera Y, et al
    The Japan Marrow Donor Program, 25 years of experience in achieving 20,000 bone marrow transplantations: organization structure, activity, and financial basis.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-017-0084.
    PubMed     Text format     Abstract available


  144. MERKER M, Meister MT, Rettinger E, Jarisch A, et al
    Haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk soft tissue sarcomas: results of a single-center prospective trial.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-018-0088.
    PubMed     Text format    


  145. KHOURY HJ, Langston AA, Kota VK, Wilkinson JA, et al
    Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-017-0081.
    PubMed     Text format     Abstract available


  146. JIMENEZ-UBIETO A, Grande C, Caballero D, Yanez L, et al
    Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry.
    Bone Marrow Transplant. 2018 Jan 23. pii: 10.1038/s41409-018-0096.
    PubMed     Text format    


  147. ROBERT S, Albring JC, Frebel K, Opitz C, et al
    Alloantigen expression on malignant cells and healthy host tissue influences graft-versus-tumor reactions after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 23. pii: 10.1038/s41409-017-0071.
    PubMed     Text format     Abstract available


  148. LAHOUD OB, Moskowitz AJ, Horwitz SM, Giralt SA, et al
    Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma.
    Bone Marrow Transplant. 2018 Jan 22. pii: 10.1038/s41409-017-0086.
    PubMed     Text format    


  149. DIEP PP, Melberg HO, Brinch L, Buechner J, et al
    Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway.
    Bone Marrow Transplant. 2018 Jan 22. pii: 10.1038/s41409-018-0091.
    PubMed     Text format    


  150. MOHAMMED J, AlGhamdi A, Hashmi SK
    Full-body physical therapy evaluation for pre- and post-hematopoietic cell transplant patients and the need for a modified rehabilitation musculoskeletal specific grading system for chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 Jan 18. pii: 10.1038/s41409-017-0075.
    PubMed     Text format    


  151. FRANGOUL H, Evans M, Isbell J, Bruce K, et al
    Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide.
    Bone Marrow Transplant. 2018 Jan 16. pii: 10.1038/s41409-017-0077.
    PubMed     Text format    


  152. BAYDOUN M, Barton DL
    Complementary therapies for fatigue after hematopoietic stem cell transplantation: an integrative review.
    Bone Marrow Transplant. 2018 Jan 16. pii: 10.1038/s41409-017-0073.
    PubMed     Text format     Abstract available


  153. ROBINSON SP, Boumendil A, Finel H, Peggs KS, et al
    Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0067.
    PubMed     Text format     Abstract available


  154. HUO MR, Pei XY, Li D, Chang YJ, et al
    Impact of HLA allele mismatch at HLA-A, -B, -C, -DRB1, and -DQB1 on outcomes in haploidentical stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0072.
    PubMed     Text format     Abstract available


  155. CALORE E, Marzollo A, Cananzi M, Pizzi M, et al
    Haploidentical stem cell transplantation cures autoimmune hepatitis and cerebrovascular disease in a patient with sickle cell disease.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0065.
    PubMed     Text format    


  156. SCHUMACHER H, Stuwe S, Kropp P, Diedrich D, et al
    A prospective, randomized evaluation of the feasibility of exergaming on patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0070.
    PubMed     Text format     Abstract available


  157. REDDIVALLA N, Robinson AL, Reid KJ, Radhi MA, et al
    Using liver elastography to diagnose sinusoidal obstruction syndrome in pediatric patients undergoing hematopoetic stem cell transplant.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0064.
    PubMed     Text format     Abstract available


  158. SHICHIJO T, Fuji S, Tajima K, Kubo H, et al
    Beneficial impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation: focusing on difference between stem cell sources.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0045.
    PubMed     Text format    


  159. WALLACE G, Myers KC, Teusink-Cross A, Davies SM, et al
    Topical vitamin D analog for chronic graft versus host disease of the skin.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0031.
    PubMed     Text format    


  160. SCHMALBROCK LK, Bonifacio L, Bill M, Jentzsch M, et al
    Prognostic relevance of DNMT3A R882 mutations in AML patients undergoing non-myeloablative conditioning hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0060.
    PubMed     Text format    


  161. GAUTHIER J, Poire X, Gac AC, Leclerc M, et al
    Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0018.
    PubMed     Text format     Abstract available


  162. KATZ MC, Michaelis S, Siegmund DM, Koch R, et al
    Association analysis between SUFU polymorphism rs17114808 and acute graft versus host disease after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0059.
    PubMed     Text format    


  163. FERREIRA AM, Pontes da Silva CA, Pereira AD, Szor RS, et al
    Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0068.
    PubMed     Text format    


  164. HAYASHI H, Ruggeri A, Volt F, Cornelissen JJ, et al
    Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0061.
    PubMed     Text format    


  165. JONES L, Dandoy C, Jodele S, Myers KC, et al
    Successful management of concurrent acquired hemophilia A and a lupus anticoagulant in a pediatric hematopoietic stem cell transplant patient.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0041.
    PubMed     Text format    


  166. LIU Y, Xu L, Zhang X, Wang Y, et al
    Acute kidney injury following haplo stem cell transplantation: incidence, risk factors and outcome.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0030.
    PubMed     Text format    


  167. CHEN Y, Lu J, Xu LP, Chen H, et al
    Safety and efficacy of haploidentical stem cell transplantation for multiple myeloma.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0069.
    PubMed     Text format    


  168. OLIVIERI J, Attolico I, Nuccorini R, Pascale SP, et al
    Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0051.
    PubMed     Text format     Abstract available


  169. OGAWA H, Ikegame K, Daimon T, Uchida N, et al
    Impact of pretransplant leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0028.
    PubMed     Text format    


  170. FERNANDES JF, Bonfim C, Kerbauy FR, Rodrigues M, et al
    Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0015.
    PubMed     Text format     Abstract available


  171. DEVILLIER R, Labopin M, Chevallier P, Ledoux MP, et al
    Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Ma
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0043.
    PubMed     Text format     Abstract available


  172. SCHOEMANS HM, Goris K, Van Durm R, Vanbrabant K, et al
    Accuracy and usability of the eGVHD app in assessing the severity of graft-versus-host disease at the 2017 EBMT annual congress.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0017.
    PubMed     Text format    


  173. MAYER K, Schumacher M, Eis-Hubinger AM, Pietzonka S, et al
    Intravesical cidofovir application in BK virus cystitis after allogeneic hematopoetic stem cell transplantation (HSCT) is safe and highly effective.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0044.
    PubMed     Text format    


    December 2017
  174. JUDET A, Copie-Bergman C, Zemoura L, Catherinot E, et al
    Epithelial chimerism in lung tissue after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0050.
    PubMed     Text format    


  175. FALCONE U, Jiang H, Bashir S, Tsang R, et al
    Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0054.
    PubMed     Text format    


  176. DEOTARE U, Atenafu EG, Loach D, Michelis FV, et al
    Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0053.
    PubMed     Text format    


  177. MITRUS I, Smagur A, Fidyk W, Czech M, et al
    Reduction of DMSO concentration in cryopreservation mixture from 10% to 7.5% and 5% has no impact on engraftment after autologous peripheral blood stem cell transplantation: results of a prospective, randomized study.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0056.
    PubMed     Text format     Abstract available


  178. SEE WQ, Tung JY, Cheuk DK, Hwang YY, et al
    Endocrine complications in patients with transfusion-dependent thalassaemia after haemopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0052.
    PubMed     Text format    


  179. KUSKONMAZ B, Ayvaz D, Tezcan I, Yuce A, et al
    Successful hematopoietic stem cell transplantation after myeloablative conditioning in three patients with dedicator of cytokinesis 8 deficiency (DOCK8) related Hyper IgE syndrome.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0040.
    PubMed     Text format    


  180. DIROU S, Chambellan A, Chevallier P, Germaud P, et al
    Deconditioning, fatigue and impaired quality of life in long-term survivors after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0057.
    PubMed     Text format     Abstract available


  181. LOPEZ-INIGUEZ A, Carrera-Villanueva KA, Leon-Rodriguez E, Cuellar-Rodriguez J, et al
    Recurrent arthritis and immune reconstitution inflammatory syndrome in hematopoietic stem cell transplantation (HSCT).
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0058.
    PubMed     Text format    


  182. RAGON BK, Mehta RS, Gulbis AM, Saliba RM, et al
    Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0034.
    PubMed     Text format     Abstract available


  183. SWEISS K, Anderson J, Wirth S, Oh A, et al
    A prospective study of intravenous pentamidine for PJP prophylaxis in adult patients undergoing intensive chemotherapy or hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0024.
    PubMed     Text format     Abstract available


  184. SIDANA S, Tandon N, Gertz MA, Dispenzieri A, et al
    Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0020.
    PubMed     Text format     Abstract available


  185. NGUYEN VP, Brauneis D, Kaku M, Sloan JM, et al
    Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0048.
    PubMed     Text format    


  186. VAN GORKOM G, van Gelder M, Eikema DJ, Blok HJ, et al
    Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT.
    Bone Marrow Transplant. 2017 Dec 18. pii: 10.1038/s41409-017-0023.
    PubMed     Text format     Abstract available


  187. UHM J, Shin E, Michelis FV, Thyagu S, et al
    Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment.
    Bone Marrow Transplant. 2017 Dec 15. pii: 10.1038/s41409-017-0025.
    PubMed     Text format    


    November 2017
  188. LEHRER J, Brissot E, Ruggeri A, Dulery R, et al
    Medication adherence among allogeneic hematopoietic stem cell transplant recipients: a pilot single-center study.
    Bone Marrow Transplant. 2017 Nov 20. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  189. FAROWSKI F, Bucker V, Vehreschild JJ, Biehl L, et al
    Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  190. CROCCHIOLO R, Ringden O, Bay JO, Blaise D, et al
    Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  191. CHAKRABORTY R, Muchtar E, Kumar SK, Buadi FK, et al
    Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  192. DOWLING MR, Li S, Dey BR, McAfee SL, et al
    Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


    October 2017
  193. ALBERT E, Solano C, Gimenez E, Focosi D, et al
    The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2017 Oct 30. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  194. SIVARAJ D, Bacon W, Long GD, Rizzieri DA, et al
    High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma.
    Bone Marrow Transplant. 2017 Oct 30. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  195. SHIN DY, Lee JH, Park S, Lee JO, et al
    Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies.
    Bone Marrow Transplant. 2017 Oct 30. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  196. JEKER B, Novak U, Mansouri Taleghani B, Baerlocher GM, et al
    NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma.
    Bone Marrow Transplant. 2017 Oct 23. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  197. O'DWYER DN, Duvall AS, Xia M, Hoffman TC, et al
    Transbronchial biopsy in the management of pulmonary complications of hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 23. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  198. SHANIS D, Anandi P, Grant C, Bachi A, et al
    Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  199. MICHNIACKI TF, Mulcahy Levy JM, Quinones RR, Giller RH, et al
    Successful correction of familial hemophagocytic lymphohistiocytosis using prenatal genetic testing and preemptive hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  200. JOFFE E, Rosenberg D, Rozovski U, Perry C, et al
    Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin's and non-Hodgkin's B-cell lymphoma.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  201. KANSAGRA A, Inwards DJ, Ansell SM, Micallef IN, et al
    Infusion of autograft natural killer cell/CD14+HLA-DRDIM cell ratio predicts survival in lymphoma post autologous stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  202. GOLDSMITH SR, Slade M, DiPersio JF, Westervelt P, et al
    Donor-lymphocyte infusion following haploidentical hematopoietic cell transplantation with peripheral blood stem cell grafts and PTCy.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  203. FOUZIA NA, Edison ES, Lakshmi KM, Korula A, et al
    Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  204. HEMMATI PG, Pfeifer K, Vuong LG, Jehn CF, et al
    Allogeneic stem cell transplantation for non-de novo AML or advanced myelodysplastic syndromes: influence of GvHD and donor lymphocyte infusions on long-term outcome.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  205. YOSHIMURA K, Yano I, Yamamoto T, Kawanishi M, et al
    Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  206. GERULL S, Denhaerynck K, Chalandon Y, Halter JP, et al
    Lack of association between relationship status and clinical outcome in allogeneic stem cell transplantation-the Swiss Transplant Cohort Study.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  207. CHO C, Hsu M, Barba P, Maloy MA, et al
    Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  208. RE A, Gini G, Rupolo M, Levis A, et al
    Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  209. KROGER N, Bishop M, Giralt S, Wayne A, et al
    Third International workshop on the biology, prevention, and treatment of relapse after stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  210. KHOSLA J, Yeh AC, Spitzer TR, Dey BR, et al
    Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.
    Bone Marrow Transplant. 2017 Oct 2. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  211. GALIENI P, Troiani E, Bigazzi C, Mazzotta S, et al
    Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 2. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  212. LIU C, Frank DN, Horch M, Chau S, et al
    Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors.
    Bone Marrow Transplant. 2017 Oct 2. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


    September 2017
  213. MONTEFUSCO V, Mussetti A, Rezzonico F, Maura F, et al
    Allogeneic stem cell transplantation and subsequent treatments as a comprehensive strategy for long-term survival of multiple myeloma patients.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  214. ALMICI C, Skert C, Bruno B, Bianchetti A, et al
    Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  215. SCHEID C, de Wreede L, van Biezen A, Koenecke C, et al
    Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  216. KUBA K, Esser P, Mehnert A, Johansen C, et al
    Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


    May 2017
  217. MALLHI K, Orchard PJ, Miller WP, Cao Q, et al
    Non-myeloablative conditioning for second hematopoietic cell transplantation for graft failure in patients with non-malignant disorders: a prospective study and review of the literature.
    Bone Marrow Transplant. 2017;52:726-732.
    PubMed     Text format     Abstract available


    January 2017
  218. HAVERKOS BM, Huang Y, Elder P, O'Donnell L, et al
    A single center's experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


    February 2016
  219. MASOURIDI-LEVRAT S, Simonetta F, Beauverd Y, Tsopra O, et al
    Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants.
    Bone Marrow Transplant. 2016 Feb 8. doi: 10.1038/bmt.2015.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: